Design Therapeutics, Inc.
DSGN · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
George Simeon: Form 4
Insider disclosure · Filed · Report period 09 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- DSGN · 25056L103 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001807120 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- DSGN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 6005 Hidden Valley Road, Suite 110, Carlsbad, CA, 92011
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields